1. Hyper IgE Syndrome and Renal Cell Carcinoma
   Neel H. Patel et al, 2017, Case Reports in Urology CrossRef
2. Not Just an Adhesion Molecule: LFA-1 Contact Tunes the T Lymphocyte Program
   Navin Kumar Verma et al, 2017, J.I. CrossRef
3. Study of the tumor microenvironment during breast cancer progression
   Rahil Eftekhari et al, 2017, Cancer Cell Int CrossRef
4. Immune-based identification of cancer patients at high risk of progression
   Yann-Alexandre Vano et al, 2018, Current Opinion in Immunology CrossRef
5. Functional status of immune cells in patients with long-lasting type 2 diabetes mellitus
   H. W. Nam et al, 2018, Clin Exp Immunol CrossRef
6. Correlation between microRNA-21 and expression of Th17 and Treg cells in microenvironment of rats with hepatocellular carcinoma
   Shao-Xin Yao et al, 2015, Asian Pacific Journal of Tropical Medicine CrossRef
7. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
   Yasin Şenbabaoğlu et al, 2016, Genome Biol CrossRef
8. Immune Th17 lymphocytes play a critical role in the multiple beneficial properties of resveratrol
   Dominique Delmas et al, 2019, Food and Chemical Toxicology CrossRef
9. The Roles of CD4+ T-Cells in Tumor Immunity
   Soheil Tavakolpour et al, 2020 CrossRef
10. Comprehensive Analysis of Copy Number Variations in Kidney Cancer by Single-Cell Exome Sequencing
    Wenyang Zhou et al, 2020, Front. Genet. CrossRef
11. The Effect of Chinese Traditional Medicine Huaiqihuang (HQH) on the Protection of Nephropathy
    Xueyan Zhang et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
12. Prognostic impact of tumor‑infiltrating CD276/Foxp3‑positive lymphocytes and associated circulating cytokines in patients undergoing radical nephrectomy for localized renal cell carcinoma
    Kota Iida et al, 2019, Oncol Lett CrossRef
13. The CCL20-CCR6 Axis in Cancer Progression.
    Suguru Kadomoto et al, 2020, Int J Mol Sci CrossRef
14. The immunology of renal cell carcinoma.
    C Marcela Díaz-Montero et al, 2020, Nat Rev Nephrol CrossRef
15. Recent advances in the role of Th17/Treg cells in tumor immunity and tumor therapy
    Yin Qianmei et al, 2021, Immunol Res CrossRef
16. Tumor-associated neutrophils activated by tumor-derived CCL20 (C-C motif chemokine ligand 20) promote T cell immunosuppression via programmed death-ligand 1 (PD-L1) in breast cancer
    Louis Boafo Kwantwi et al, 2021, Bioengineered CrossRef
17. Multifaceted roles of CCL20 (C-C motif chemokine ligand 20): mechanisms and communication networks in breast cancer progression
    Louis Boafo Kwantwi et al, 2021, Bioengineered CrossRef
18. Gene regulation of Intracellular adhesion Molecule-1 (ICAM-1): A molecule with multiple functions
    Mona Singh et al, 2021, Immunology Letters CrossRef
19. From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma
    Jonathan Anker et al, 2021, Cells CrossRef
20. Cancer and Autoimmune Diseases: A Tale of Two Immunological Opposites?
    Zeev Elkoshi, 2022, Front. Immunol. CrossRef
21. Nonsense-Mediated Decay Targeted RNA (ntRNA): Proposal of a ntRNA–miRNA–lncRNA Triple Regulatory Network Usable as Biomarker of Prognostic Risk in Patients with Kidney Cancer
    Zhiyue Zhou et al, 2022, Genes CrossRef
22. The role of cytokines and T-bet, GATA3, ROR-γt, and FOXP3 transcription factors of T cell subsets in the natural clinical progression of Type 1 Diabetes
    Burcin Aydin Ozgur et al, 2023, Immunol Res CrossRef
23. ARHGAP11A Is a Novel Prognostic and Predictive Biomarker Correlated with Immunosuppressive Microenvironment in Clear Cell Renal Cell Carcinoma
    Huihui Yang et al, 2023, IJMS CrossRef
24. Acquired DNA damage repairs deficiency-driven immune evolution and involved immune factors of local versus distant metastases in non-small cell lung cancer
    Wen-Fang Tang et al, 2023, OncoImmunology CrossRef
25. Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC
    Arighno Das et al, 2023, Nat Rev Urol CrossRef
26. Predicting response of immunotherapy and targeted therapy and prognosis characteristics for renal clear cell carcinoma based on m1A methylation regulators
    Lei Li et al, 2023, Sci Rep CrossRef
27. Exogenous APN protects normal tissues from radiation-induced oxidative damage and fibrosis in mice and prostate cancer patients with higher levels of APN have less radiation-induced toxicities
    Joshua A. McDowell et al, 2024, Redox Biology CrossRef
28. Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients
    Mengjiao Zhang et al, 2024, BMC Med Genomics CrossRef
29. Complex Role of Regulatory T Cells (Tregs) in the Tumor Microenvironment: Their Molecular Mechanisms and Bidirectional Effects on Cancer Progression
    Yu Wang et al, 2024, IJMS CrossRef
30. Th17/Treg cell balance in patients with papillary thyroid carcinoma: a new potential biomarker and therapeutic target
    Meng-Han Huo et al, 2024, Front. Oncol. CrossRef
31. Gut microbiota contributes to the intestinal and extraintestinal immune homeostasis by balancing Th17/Treg cells
    Jing Wang et al, 2024, International Immunopharmacology CrossRef